Date: 2021-09-07
Time:
16:00 - 17:00 UTC
17:00 -18:00 BST
Zoom Meeting Details
Topic: Diabetes Clinical Project Group Conference Call
Join from PC, Mac, Linux, iOS or Android:
https://snomed.zoom.us/j/95678555424?pwd=d09OVmRHNmdQR0lEaVVJOHpRK2lHUT09
Password: 286483
Or Skype for Business (Lync):
https://snomed.zoom.us/skype/95678555424
Attendees
Chair:
DCPG Members
- Anthony Khawaja
- David Rocha
- Steve Jackson
- Charlie Stuart-Buttle
- Alasdair Warwick
- Tasso Gazis
Observers:
Apologies:
- Cathy Richardson
- Grahame Sterling
- Peter Davis
Meeting Files:
Objectives
- Obtain consensus on agenda items
Discussion items
Item | Description | Owner | Notes | Action |
---|---|---|---|---|
1 | Call to order and role call | This meeting is being recorded to ensure that important discussion points are not missed in the minutes. The recording will be available to the SNOMED International community. If a majority of participants object to recording, only written minutes will be available, otherwise, anyone objecting to recording is requested to exit the meeting. |
| |
2 | Conflicts of interest and agenda review | None stated. | ||
3 | Can one distinguish between a diabetic cataract and a senile cataract? | ALL | Discussion: There does not appear to be any evidence that a cataract in a diabetic has characteristics that are any different to those identified in a cataract associated with advancing years. There is evidence that supports the notion that cataracts may begin at an earlier age and/or progress more quickly in diabetics than in those who are not diabetics. Decision: Given that there is no evidence that cataracts are causally related to diabetes the consensus is that existing content should be inactivated as erroneous with a historical association to:
as appropriate. Update: Literature, including statements by WHO while not supporting the causal relationship between diabetes mellitus do confirm that there is an apparent increase in incidence of cataracts and that they tend to appear earlier in diabetics. Do the group agree, and if so, should we consider changing existing content from 43959009 |Cataract of eye due to diabetes mellitus (disorder)| to "Cataract of eye with diabetes mellitus" where the "with" indicates that the associated disorder is co-occurrent with diabetes but no causal relationship is thought to exist and this would be reflected in the modeling? | |
4 | Macula disorders | AK | Some of these concepts include adjectives:
Is it possible to define these in a way that supports interoperability? Discussion: Content within the Macular disorder and Proliferative and non-proliferative retinopathy sections are impacted by the use of these adjectives. While there is often a lack of consistency and/or vagueness in the definition of these adjectives there are some used in retinal screening and elsewhere that have reasonably well accepted definition. Depending on the context some clinicians will record individual retinal findings whereas others may simply review a retinal photograph and grade it according the accepted protocol. Decision: The group will review existing content where adjectives have been used and identify those concepts that have an internationally agreed definition and those that do not, where possible providing references, for discussion at the next meeting. Discussion 20211005: Review of definitions: | |
5 | Proliferative and non-proliferative retinopathy | ALL | Some of our group feel that these concepts are predominantly available to serve the purposes of the diabetic screening services and that from the perspective of day to day management of the diabetic patient they are less helpful. The intention is to discuss this in depth at our next meeting as part of the feedback from Eye Complications 2 but to introduce the topic now in preparation for the next meeting Discussion: Partially discussed as part of item 5 above. Decision: Carried forward for discussion at the next meeting. | |
6 | Review of eye findings relating to eye disorders caused by diabetes | ALL | ||
9 | AOB | ALL | ||
10 | Next meeting | ALL | Next conference call |
|